A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer
Clinical trial NCT03472053 · COMPLETED
Trial details
- NCT number
- NCT03472053
- Sponsor
- BioMarck Pharmaceuticals, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2019-12-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.